SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Shukra Pharmaceuticals Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524632 INE551C01044 1.5028279 Not Listed 0.02 2,572.98 217.63 0.27 1
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales5.885.3913.27
Other Operating Income0.000.000.00
Other Income 1.711.111.47
Total Income7.596.5014.74
Total Expenditure 6.304.075.95
PBIDT1.292.438.78
Interest 0.290.270.27
PBDT1.012.168.51
Depreciation0.810.790.94
Tax0.000.412.18
Fringe Benefit Tax0.000.000.00
Deferred Tax-2.18-0.060.00
Reported Profit After Tax2.381.035.39
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item2.381.035.39
    
EPS (Unit Curr.)0.050.020.12
EPS (Adj) (Unit Curr.)0.050.020.12
Calculated EPS (Unit Curr.)0.050.020.12
Calculated EPS (Adj) (Unit Curr.)0.050.020.12
Calculated EPS (Ann.) (Unit Curr.)0.220.090.49
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.220.090.49
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity43.7943.7943.79
Reserve & Surplus22.020.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)21.9445.0866.16
PBDTM(%)17.1840.0764.13
PATM(%)40.4819.1140.62